Tirzepatide as an Add-on for Participants with Inadequate Glycemic Control Using Basal Insulin-Pooled Subgroup Analysis of SURPASS-5 and-6

被引：0
|
作者：
Bajaj, Harpreet S.
Billings, Liana K.
Liu, Minzhi
Levine, Joshua A.
Rodriguez, Angel
Patel, Hiren
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-749-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
749-P
引用
收藏
页数：2
相关论文
共 6 条
  • [1] Tirzepatide as an add-on for participants with inadequate glycaemic control using basal insulin: pooled subgroup analysis of SURPASS-5 and-6
    Rodriguez, A.
    Bajaj, H.
    Billings, L. K.
    Liu, M.
    Levine, J. A.
    Patel, H.
    DIABETOLOGIA, 2024, 67 : S361 - S361
  • [2] Patient-reported outcomes in patients with type 2 diabetes treated with tirzepatide or placebo as an add-on to basal insulin (SURPASS-5)
    Yu, M.
    Boye, K.
    Huh, R.
    Patel, H.
    Rodriguez, A.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 244 - 245
  • [3] Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes The SURPASS-5 Randomized Clinical Trial
    Dahl, Dominik
    Onishi, Yukiko
    Norwood, Paul
    Huh, Ruth
    Bray, Ross
    Patel, Hiren
    Rodriguez, Angel
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (06): : 534 - 545
  • [4] Exenatide Once Weekly Versus Daily Basal Insulin as Add-on Treatment to Metformin With or Without a Sulfonylurea: A Retrospective Pooled Analysis in Patients With Poor Glycemic Control
    Grimm, Michael
    Li, Yan
    Brunell, Steven C.
    Blase, Erich
    POSTGRADUATE MEDICINE, 2013, 125 (05) : 101 - 108
  • [5] Efficacy of ipragliflozin as monotherapy or as add-on therapy with other oral antidiabetic medications for treating type2 diabetes in Japanese patients with inadequate glycemic control: A subgroup analysis based on patient characteristics
    Osonoi, Takeshi
    Nakamoto, Shinya
    Saito, Miyoko
    Tamasawa, Atsuko
    Ishida, Hidenori
    Osonoi, Yusuke
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (02) : 341 - 353
  • [6] Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6)
    Boye, Kristina Secnik
    Poon, Jiat Ling
    Lando, Laura Fernandez
    Sapin, Helene
    Huh, Ruth
    Wang, Mianbo
    Williamson, Suzanne
    Patel, Hiren
    DIABETES THERAPY, 2024, 15 (09) : 2039 - 2059
1